Sanara MedTech (SMTI) Net Income towards Common Stockholders (2010 - 2026)

Sanara MedTech has reported Net Income towards Common Stockholders for 16 years, with the latest figure at $60916.0 in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 102.1% year-over-year to $60916.0; the trailing twelve-month figure through Mar 2026 stood at -$33.5 million (down 184.63% YoY), and the FY2025 full-year result was -$37.2 million, down 366.18% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $60916.0, up from -$502848.0 in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $60916.0 in Q1 2026, with the low at -$31.2 million in Q3 2025.
• Historically, Net Income towards Common Stockholders has averaged -$3.7 million across 5 years, with a median of -$1.9 million in 2023.
• Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders sank 1056.18% — and 2026, when it surged 102.1%.
• Sanara MedTech's Net Income towards Common Stockholders stood at -$4.2 million in 2022, then soared by 93.76% to -$262444.0 in 2023, then plunged by 904.14% to -$2.6 million in 2024, then surged by 80.92% to -$502848.0 in 2025, then soared by 112.11% to $60916.0 in 2026.
• The last three Net Income towards Common Stockholders figures came in at $60916.0 (Q1 2026), -$502848.0 (Q4 2025), and -$31.2 million (Q3 2025), per Business Quant data.